Navigation Links
Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
Date:9/27/2007

BOTHELL, Wash., Sept. 27 /PRNewswire/ -- Verathon Inc. is pleased to introduce the GlideScope(R) Ranger Single Use video laryngoscope that provides a clear, real-time view of the airway and endotracheal tube placement, enabling quick intubation. Optimized for demanding Emergency Department (ED), EMS and military applications, the GlideScope(R) Ranger Single Use design, which eliminates the need for disinfecting the "blade," is ideal for fast-paced intubation settings.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO)

Designed for "1st Pass Success," GlideScope(R) video laryngoscopes provide a real time view of the airway and of endotracheal tube placement, minimizing the need for a "blind" intubation procedure. The GlideScope(R) Ranger Single Use design is based on the GlideScope(R) reusable video laryngoscope that achieves a Cormack-Lehane Grade I or Grade II view 99 percent of the time.(i)

"The GlideScope(R) Ranger has become very popular with Emergency personnel over the past year," said Dr. John Pacey, inventor of the GlideScope(R) and President of Verathon Medical(R) Canada ULC. "EMS personnel appreciate the view, ease of use, portability and ruggedness of the device. Their only request was for a single-use version, so they could eliminate the wait that comes from disinfecting a reusable instrument."

The GlideScope(R) Ranger Single Use consists of: a slim video baton which houses a high-resolution camera with a patented anti-fogging mechanism to resist lens contamination; a non-glare color monitor that is easily seen in bright light; and single-use, sterile GVL(R) Stats in large and small sizes that offer a patented 60-degree blade angulation.

The GlideScope(R) Ranger was designed to meet the needs of military physicians and paramedics who work in extreme conditions and regularly treat patients with severe trauma. Endotracheal i
'/>"/>

SOURCE Verathon Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. E Merck introduces Livogen Z with zinc sulphate
2. TI Cycles Introduces Foldman
3. Canada Introduces Mandatory Nutrition Labeling
4. Amgen introduces Autoinjector For Treating Anemia
5. Cuba Introduces New Device for Detecting Vascular Diseases
6. China Introduces Solar-powered Baths
7. Allergan Introduces ‘Dermal Filler’ for Smile Lins
8. UAE Introduces Cervical Cancer Vaccine
9. Cynosure Introduces Higher Power Smartlipo(TM) LaserBodySculpting Workstation
10. Iceland Introduces Smoking Ban in Bars and Restaurants
11. Indian Introduces Paan-flavoured Condoms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...21 NursingCenter.com, the premier ...peer reviewed content, has been,updated to improv...tered,users. Powered by Lippincott Williams &...er 900 peer-reviewed continuing education activiti...han 50 leading nursing journals.,Lippincott Willi...
(Date:11/21/2008)...., Nov. 21 Today, prescr...rvention in treating 88 percent of patients suffer...ns treated for a chronic condition account for 96 ...ercent of all medical costs. A proprietary new ph...ealth Solutions, Inc. (NYSE: MHS ) significantly...
(Date:11/21/2008)...w and deadly diseaseits cause remains a mysteryswe...eming with citizens, soldiers and refugees of the ...ets filled with corpses, social order broke down. ...ice and Athens lost a third of its population. It ...beginning of the end of the Golden Age of Greece. ...
(Date:11/21/2008)...21 Symmetry Medical Inc.... products to the global orthopedic device industry...rian S. Moore, President and Chief Executive Offic...ief Financial Officer, are scheduled to present at...nce at The New York Palace Hotel on Wednesday, Dec...
Breaking Medicine News(10 mins):Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 2Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 3Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 4Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 5Health News:New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes 6Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...nducted a clinical trial of administering xenon ga...afting so that such patients are safe from // the ...is procedure. The team administered xenon gas to ...monary artery bypass. This treatment could revolut...
...apped with four additional law suits, after the Li...ad failed miserably. // Orange county Superior c...he families of patients who died just waiting for ..., a patient who never received a liver. The liver...
...fecting just your gums. It can increase the risk o...elivery. // The following is the conclusion arrive...New York. Participants at the conference highligh...ng increased risk of serious illness in associatio...
...ghts into why Africans have an increased susceptib...n of the disease compared to whites. // Worldwide...licted with TB and over 2 million people die due t...ycobacterium tuberculosis. According to official s...
Other Medicine News:Health News:Xenon Could Limit Nerve Damage After Stroke 2Health News:Unhealthy Gums Increase Risk Of Premature Delivery 2Health News:Vitamin D May Help In Fight Against Tuberculosis 2
(Date:11/21/2008)...nd, November 21 , ...mmittee for Medicinal Products for Human Use (CHMP... the approval of Enbrel(R),(etanercept) as a trea...escents with severe plaque psoriasis. If approved ...ee,s recommendation, Enbrel will become the,first...
(Date:11/20/2008)... , PHILADELPHIA, Nov. 20 /PRNewswire-FirstCall... that the United States Food and Drug Administrati...(R) (eltrombopag) for the treatment of thrombocyto... thrombocytopenic purpura (ITP) who have had an in...ulins or splenectomy. The approval is a significan...
(Date:11/20/2008)... Nov. 20 Duska Therapeut...today that it has submitted its,pivotal Phase 3 A...pecial,Protocol Assessment (SPA) procedure with t... Subject to securing an agreement with the FDA,... double-blind, placebo-controlled and randomized P...
(Date:11/19/2008)...v. 19 Posit Science Corporation,r...ociety for Neuroscience,Annual Conference in Wash...aining may benefit Baby Boomers. The computerized...) uses adaptive exercises that target auditory and... drive generalized,improvements in cognition by i...
Breaking Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Immigrants From India Pakistan Face U S Prostate Breast Cancer Risks 2974 1Immigrants From India Pakistan Face U S Prostate Breast Cancer Risks 2974 2Extra payments to Medicare Advantage plans to total 248 5 billion in 2008 26084 1Extra payments to Medicare Advantage plans to total 248 5 billion in 2008 26084 2ISU researchers help map first plant parasitic nematode genome sequence 4736 1ISU researchers help map first plant parasitic nematode genome sequence 4736 2Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 1Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 2Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 3Zimmer Holdings Inc Announces Agreement to Acquire Abbott Spine an Innovator in Spinal Technology 7493 4
...March 8, 2007--The World Health Organization,has r... rising in,Pakistan. , So is this another instance...armaceutical industry is denying important vaccine...rding to London’s Guardian,newspaper, &ldquo...efused to allow health workers to administer polio...
...USINESS WIRE)--Mar 8, 2007 - Magen BioSciences,In...ed the,publication of a paper in the March 9, 2007...oard member, David E. Fisher, M.D.,Ph.D., that id...n,p53, in the pigmentation of skin. Fisher,s stud...r suppressor in other cancers in,the body, p53 als...
Other Medicine Technology:Why Is Polio Spreading in Pakistan? 2Study in Cell by Magen BioSciences Co-Founder David E. Fisher,Identifies New Roles in Skin Cancer Prevention for Key Tumor,Suppressor Protein 2
...est addition to the Primus family of fine products...speed and accuracy in a flexible unit ideal for lo...nutes using proven accurate boronate affinity tech... comes equipped with simple, menu-driven software,...
...poration launched the first generation HPLC system...ught a new level of automation to HPLC and placed ...n. Now in the United States, Tosohs seventh genera...able HbA1c results in 2.2 minutes, -thalassemia te...
Micromat II Hemoglobin A1c instrument is an easy-to-use, accurate and precise instrument with an requirement of only 10 L of capillary or venous sample.
The sole coagulation analyzer in the world that uses a unique dry reagent card.
Medicine Products: